Mandato Vincenzo Dario, Perrone Anna Myriam, Pirillo Debora, Ciarlini Gino, Annunziata Gianluca, Arena Alessandro, Alboni Carlo, Di Monte Ilaria, Capozzi Vito Andrea, Amadori Andrea, Martinello Ruby, Rosati Federica, Stefanetti Marco, Palicelli Andrea, Santandrea Giacomo, Seracchioli Renato, Berretta Roberto, Aguzzoli Lorenzo, Torricelli Federica, De Iaco Pierandrea
Unit of Obstetrics and Gynecologic Oncology, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.
Division of Oncologic Gynecology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Cancers (Basel). 2025 Jul 7;17(13):2261. doi: 10.3390/cancers17132261.
: Following the results of the Laparoscopic Approach to Carcinoma of the Cervix (LACC) trial, doubts have arisen about the safety of laparoscopy in the treatment of endometrial cancer. A retrospective multicenter cohort study which included all endometrial cancer (EC) patients who underwent a hysterectomy in Emilia Romagna hospitals from 2000 to 2019. All cases were revised and classified according to the 2009 International Federation of Gynaecology and Obstetrics (FIGO) staging system. The different impacts of the surgical approach on survival were stratified according to the recurrence risk from the 2016 European Society for Medical Oncology (ESMO)-European Society of Gynaecological Oncology (ESGO) classification system. The clinical characteristics and oncological outcome of patients treated by laparoscopy were compared with those treated by laparotomy. A total of 2402 EC patients were included in the study. The use of laparoscopy has increased over the years, reaching 81% of procedures in 2019. Laparoscopy reduced complications and hospital stay. Laparoscopy was preferred to treat low, intermediate, and intermediate/high-risk patients. Laparoscopy showed no adverse effects on overall survival (OS) in any recurrence risk class. Particularly in high-risk EC patients, laparoscopy was associated with an increased OS in comparison with women treated by laparotomy regardless of the use of adjuvant therapy. Laparoscopy should always be chosen to treat EC of any risk class. The goal is to ensure correct treatment and oncological safety regardless of the surgical approach.
根据子宫颈癌腹腔镜手术方法(LACC)试验的结果,人们对腹腔镜手术治疗子宫内膜癌的安全性产生了怀疑。一项回顾性多中心队列研究纳入了2000年至2019年在艾米利亚-罗马涅地区医院接受子宫切除术的所有子宫内膜癌(EC)患者。所有病例均根据2009年国际妇产科联盟(FIGO)分期系统进行复查和分类。根据2016年欧洲医学肿瘤学会(ESMO)-欧洲妇科肿瘤学会(ESGO)分类系统的复发风险,对手术方式对生存的不同影响进行分层。将腹腔镜手术治疗患者的临床特征和肿瘤学结局与开腹手术治疗患者进行比较。该研究共纳入2402例EC患者。多年来腹腔镜手术的使用有所增加,2019年达到手术总数的81%。腹腔镜手术减少了并发症和住院时间。腹腔镜手术更适合治疗低、中、中/高风险患者。在任何复发风险类别中,腹腔镜手术对总生存期(OS)均无不良影响。特别是在高危EC患者中,与开腹手术治疗的女性相比,无论是否使用辅助治疗,腹腔镜手术均与OS增加相关。对于任何风险类别的EC,都应始终选择腹腔镜手术进行治疗。目标是无论采用何种手术方式,都要确保正确的治疗和肿瘤学安全性。